Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study

Autor: Rubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, Juan González-García, Oscar Brochado-Kith, Amanda Fernández-Rodríguez, Cristina Díez, Victor Hontañon, The Marathon Study Group, Salvador Resino, María Ángeles Jiménez-Sousa, A. Arranz, F. Arnalich, J. R. Arribas, E. Aznar, T. Aldamiz-Echevarría, J. Bermejo, J. Berenguer, J. M. Bellón, I. Bernardino, M. J. Bustinduy, A. Carrero, S. Carretero, E. Casas, J. L. Casado, M. Crespo, P. Crespo, C. Díez, M. Díaz, J. de Miguel, F. Dronda, H. Esteban, C. Fanciulli, A. Ferrer, M. J. Galindo, J. González-García, I. Gutiérrez, A. Iribarren, V. Hontañón, C. López, P. Miralles, M. L. Montes, A. Moreno, S. Moreno, L. Ortiz, E. Ortega, B Padilla, J. F. Parras, L. Pérez-Latorre, F. Pascual, M. Pérez, M. J. Pérez-Elías, J. M. Peña, C. Quereda, M. Ramírez, E. Ribera, J. F. Rodríguez-Arrondo, J. Sanz, I. Santos, M. A. Sanfrutos, S. Schroeder, F. Tejerina, M. J. Téllez, E. Van den Eynde, J. Vergas, M. A. Von-Wichmann, M. Yllescas, J. F. Zamora

Publikováno v: Frontiers in Pharmacology, Vol 15 (2024)

BackgroundUnderstanding the predictors of metabolic disorders in persons with HIV/HCV coinfection post-HCV therapy is crucial for improving patient outcomes. Since immune checkpoint proteins are usually upregulated in these persons with HIV/HCV coinf

Externí odkaz: https://doaj.org/article/172bda063f904417a50997f3f3bc0faf

Minimum spread of the new Swedish variant of Chlamydia trachomatis and distribution of C. trachomatis ompA genotypes in three geographically distant areas of Spain, 2011–2012

Autor: M. A. von Wichmann, A. Bordes, Jose C. Palomares, Samuel Bernal, L. Piñeiro, R. Gilarranz, G. Cilla

Publikováno v: Infection. 42:905-912

The aim of this study was to determine the presence of the new Swedish Chlamydia trachomatis (C. trachomatis) variant (nvCT) and the distribution of C. trachomatis ompA genotypes in three geographically distant regions of Spain. The genotypes of stra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de74da98b79c9b6dbc815c7af7faad9
https://doi.org/10.1007/s15010-014-0665-6

Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly

Autor: Cristina Fernández, José Antonio Lepe, Elena Pérez-Nadales, José Ramón Blanco, A. Granados, J. Tapiol, Mariana Camoez, C. Padilla, Clara Natera, Esther Calbo, M.A. Goenaga, Guillermo Cuervo, J. Rodríguez-Baño, D. Fontanals, Margarita Salvadó, M. Pujol, Álvaro Pascual, A. Jover, Juan Pablo Horcajada, Elena Bereciartua, José Molina, María Ángeles Domínguez, Benito Almirante, Miguel Ángel Goenaga, Belén Padilla, J.P. Horcajada, Emilio Ojeda, María-Cruz Rodríguez, Irene Gracia-Ahufinger, José Antonio Martínez, Ana Arnaiz, Miquel Pujol, M. A. Morera, Fernando Rodríguez-López, María Lagarde, C. Martin, M.A. Domínguez, Francisco López-Medrano, Maria-Consol Garcia, J.M. Montejo, Fernando Chaves, Fernando Barcenilla, M. Xercavins, Javier Murillas, J A Martínez, Jesús Rodríguez-Baño, Enrique Ruiz de Gopegui, Natividad Benito, J. Torre-Cisneros, A. Arnáiz, M. Camoez, Milagro Montero, J. M. García-Arenzana, Nieves Larrosa, M. Á. von Wichmann, Vicente Pintado, René Unda Lara, B. Almirante, Oriol Gasch, Evelyn Shaw, José Miguel Montejo, E. Ruiz de Gopegui, José L. Hernández, Elena Loza, O. Gasch, E. Cercenado, J.A. Lepe, Luis Eduardo López-Cortés, Elena Espejo, Beatriz Mirelis, Carlos Dueñas, N. Benito, Francesc Marco, B. Padilla, I. Olarte, V. Pintado, G. García-Pardo, R. Sordé, F. López-Medrano

Publikováno v: The Journal of infection. 72(3)

To compare clinical and microbiological characteristics, treatment and outcomes of MRSA bacteraemia among elderly and younger patients.Prospective study conducted at 21 Spanish hospitals including patients with MRSA bacteraemia diagnosed between June

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4577df55feec19747fade165ca3b345a
https://pubmed.ncbi.nlm.nih.gov/26723914

Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

Autor: J, Berenguer, J, González-García, J, López-Aldeguer, M A, Von-Wichmann, C, Quereda, A, Hernando, J, Sanz, C, Tural, E, Ortega, J, Mallolas, I, Santos, P, Miralles, M L, Montes, J M, Bellón, H, Esteban

Publikováno v: The Journal of antimicrobial chemotherapy. 63(6)

OBJECTIVES The two currently available types of pegylated interferon (peg-IFN) used to treat hepatitis C have different pharmacokinetic properties. It is unclear how these differences affect response to therapy. We compared the effectiveness and safe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192143010932082811f27bc5291751e9
https://pubmed.ncbi.nlm.nih.gov/19363085

[Administration of granulocyte colony-stimulating factor in patients infected with human immunodeficiency virus and prolonged neutropenia]

Autor: M A, von Wichmann, X, Camino, G, Txoperena, J, Arrizabalaga, F, Rodríguez-Arrondo, J A, Iribarren

Publikováno v: Enfermedades infecciosas y microbiologia clinica. 19(1)

Persistent neutropenia is frequent in HIV infected patients with severe immunodeficiency. G-CSF induces proliferation and differentiation of granulocyte precursors. Our objective has been to assess the response to G-CSF therapy on patients with advan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3b5b76e483ea051e1200b8624bfffe9c
https://pubmed.ncbi.nlm.nih.gov/11256242